Publication: Enfermedad de Parkinson. Últimos avances en el tratamiento
Loading...
Official URL
Full text at PDC
Publication Date
2017-06
Advisors (or tutors)
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
Citations
Exportar
Abstract
El Parkinson es la segunda enfermedad neurodegenerativa más frecuente, consiste en la destrucción progresiva del tejido dopaminérgico situado en la sustancia negra del sistema nervioso central. Dicha enfermedad afecta gravemente a la calidad de vida de las personas que la padecen y aunque hay numerosos medicamentos dirigidos a su tratamiento, únicamente se ha conseguido disminuir los síntomas que el Parkinson produce pero no curar la enfermedad, además dichos fármacos tienen numerosos efectos secundarios. Por todo ello se continúa con la investigación de nuevos fármacos más eficaces y con menos reacciones adversas.
Parkinson’s is the second most frequent neurodegenerative disease based on the progressive destruction of the dopaminergic tissue located in the substantia nigra of the central nervous system. Parkinson’s disease affects the quality of life of people who suffers from it. Although there are many different drugs used for treatment, it has only been possible to reduce the symptoms that Parkinson’s produces so it is still a not curable disease. Besides, these drugs has many side effects. Therefore, research continues on more effective new drugs with less adverse reactions.
Parkinson’s is the second most frequent neurodegenerative disease based on the progressive destruction of the dopaminergic tissue located in the substantia nigra of the central nervous system. Parkinson’s disease affects the quality of life of people who suffers from it. Although there are many different drugs used for treatment, it has only been possible to reduce the symptoms that Parkinson’s produces so it is still a not curable disease. Besides, these drugs has many side effects. Therefore, research continues on more effective new drugs with less adverse reactions.